Clinical trial
Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Atrial Fibrillation Patients Defined as Population With a Low Risk of Stroke Based on a CHA2DS2-VASc Score
NCT03147911 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Atrial Fibrillation Patients Defined as Population With a Low Risk of Stroke Based on a CHA2DS2-VASc Score
- Lead sponsor
- Korea University Guro Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 6, 2017
- Completion date
- June 14, 2018
- Enrollment
- 1,181 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.